Explore the categories so you can find more about your search.
Categorie > Cardiovascular / Cardiology
Medtronic Completes Enrollment In International Post-Market Study Of Resolute Drug-Eluting Stent
Categorie : Cardiovascular / CardiologyMedtronic, Inc. (NYSE: MDT), announced completion of enrollment in RESOLUTE International, a post-market study of its Resolute Drug-Eluting Stent (DES). One-year data from this international study, which enrolled 2,464 patients at 88 sites from 17 countries in Europe, Asia, Africa, and Latin America ...
read more 
Wed May 2009
Long-Term Medtronic Device Registry First To Show How Implantable Heart Devices Work In Real-World Clinical Practice
Categorie : Cardiovascular / CardiologyThe first results from the Medtronic Inc. ...
read more Wed May 2009
Heart Charity Calls For The Government To Try Harder On Palliative Care
Categorie : Cardiovascular / CardiologyIn response to the House of Commons Public Accounts Committee End of Life Care Report published Ruairi O'Connor, Head of Policy and Public Affairs at the British Heart Foundation (BHF) said: "Today's report strongly supports points made by the 40 members of the Cardio and Vascular Coalition in its ...
read more Wed May 2009
UPMC Cardiovascular Institute Recruiting For Severe Coronary Heart Disease Study
Categorie : Cardiovascular / CardiologyThe UPMC Cardiovascular Institute currently is enrolling participants for a Phase 2 clinical trial to examine whether administering a naturally occurring protein improves blood supply to the cardiac muscle in patients with severe coronary artery disease. The study, known as Angiogenesis for the Tr ...
read more Wed May 2009
Medtronic Demonstrates Positive Results On First Pacemaker Designed For Use With MRI
Categorie : Cardiovascular / CardiologyNew data announced at Heart Rhythm 2009, the annual congress of the Heart Rhythm Society, demonstrate that patients implanted with the investigational EnRhythm MRI™ SureScan™ pacing system experienced no complications related to the use of magnetic resonance imaging (MRI). Sponsored by Medtroni ...
read more Wed May 2009
Study Sees Transient Heart Dysfunction In Some Long-Distance Runners
Categorie : Cardiovascular / CardiologyA new study using advanced cardiac imaging technology indicates that cardiac abnormalities experienced by some marathon runners following competition are temporary, and do not result in damage to the heart muscle. The study, conducted by researchers at the University of Manitoba, marked the first us ...
read more Wed May 2009
Efficacy Of CT Scans For Chest Pain Diagnosis Validated By Long-Term Study Results
Categorie : Cardiovascular / CardiologyThe first long-term study following a large number of chest pain patients who are screened with coronary computerized tomographic angiography (CTA) confirms that the test is a safe, effective way to rule out serious cardiovascular disease in patients who come to hospital emergency rooms with chest p ...
read more Wed May 2009
Mesoblast Announce Heart Muscle Function Improved After Single, Lowest-Dose Injection Of "Off-The-Shelf" Stem Cells In Patients With Heart Failure
Categorie : Cardiovascular / CardiologyAustralia's regenerative medicine company, Mesoblast Limited (ASX:MSB)(PINK:MBLTY), announced positive three-month interim efficacy results from the first 20 patients enrolled in the Phase 2 heart failure trial of the proprietary allogeneic, or "off-the-shelf", adult stem cell product Revascor(TM). ...
read more Wed May 2009
PLC Medical Systems To Demonstrate RenalGuard(R) At EuroPCR 2009
Categorie : Cardiovascular / CardiologyPLC Systems Inc. (OTC Bulletin Board: PLCSF), a company focused on innovative cardiac and vascular medical device-based technologies, announced that it will demonstrate its RenalGuard System(TM) at EuroPCR, the annual meeting of the European Association of Percutaneous Cardiovascular Interventions ( ...
read more Wed May 2009
Heating Heart With Catheter Better Than Drugs For Common Heart Rhythm Disorder
Categorie : Cardiovascular / CardiologyTreating a common heart rhythm disorder by burning heart tissue with a catheter works dramatically better than drug treatments, a major international study has found. One year after undergoing a treatment called catheter ablation, 63 percent of patients with an irregular heartbeat called atrial f ...
read more Wed May 2009
Formulations Of Three Aspirin Types Compared By Study
Categorie : Cardiovascular / CardiologyFor many years, it has been known that aspirin is beneficial to patients suffering heart attacks and near-heart attacks. But which of the many different types of aspirin is likely to help the most? A group of researchers led by Dr. Sean Nordt from the University of California, San Diego gave thre ...
read more Wed May 2009
Stem Cell Transplant In Mouse Embryo Yields Heart Protection In Adulthood
Categorie : Cardiovascular / CardiologyStem cells play a role in heart muscle rejuvenation by attracting cells from the body that develop into heart muscle cells. They have been successfully used to halt or reverse cardiac injury following heart attack, but not to prevent injury before it occurs. A new study that delivered embryonic s ...
read more Wed May 2009
Medtronic Clinical Trial Evaluating The Newest Radiofrequency Ablation Tools For Atrial Fibrillation Completes Enrollment
Categorie : Cardiovascular / CardiologyMedtronic, Inc. (NYSE:MDT) announced completion of enrollment in the TTOP-AF (Tailored Treatment of Permanent Atrial Fibrillation) clinical trial. The study is evaluating the use of the latest radiofrequency (RF) ablation technology, the Medtronic Ablation Frontiers Cardiac Ablation System, for the ...
read more Wed May 2009
Endosense Unveils TOCCATA Trial Results: The First Complete Assessment Of Force In Catheter Ablation
Categorie : Cardiovascular / CardiologyEndosense has announced the release of acute clinical results from the TOCCATA (TOuCh+ for CATheter Ablation) European clinical trial at Heart Rhythm 2009, the Heart Rhythm Society's 30th Annual Scientific Sessions in Boston, May 13 - 16. The highly anticipated results of the 76-patient, multi-cente ...
read more Wed May 2009
Medtronic-Supported Clinical Trial Shows ICD Patients Less Likely To Develop Need For Pacing When Device Uses MVP(R) Mode
Categorie : Cardiovascular / CardiologyMVP® (Managed Ventricular Pacing), exclusive programming on Medtronic pacemakers, which is proven to be effective in reducing unnecessary pacing in pacemaker patients, was applied in the MVP Trial of implantable cardioverter-defibrillator (ICD) patients. Data from MVP trial, sponsored by Medtronic, ...
read more Wed May 2009
Let's Get Moving For Heart Children's Health!
Categorie : Cardiovascular / CardiologyThe Children's Heart Federation (CHF) launches Let's Get Moving for Heart Children's Health: a call to action to include children with congenital heart disease in PE at school and to increase their access to sport in the community, at its House of Common's reception today (14 May) in the presence of ...
read more Wed May 2009
Use Of The MitraClip(R) Therapy Continues To Expand In Europe, First 100 Patients Treated
Categorie : Cardiovascular / CardiologyEvalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, announced today that the first 100 patients have been treated with the MitraClip(R) system in Europe. Clinical results to date underscore the acute clinical benefit for patients, d ...
read more Wed May 2009
Taking A Hard-Line Approach To Cardiovascular Risks In The Diabetes Patient
Categorie : Cardiovascular / CardiologyWhen treating the diabetes patient, doctors discussed how a "one size fits all" approach to testing is not enough to reveal an individual's risk for cardiovascular disease Saturday at the American Association of Clinical Endocrinologists (AACE) 18th Annual Meeting & Clinical Congress. "We need ...
read more Wed May 2009
Essentialis Meets Primary Endpoint In Phase 2b Trial Of DCCR For Treatment Of Hypertriglyceridemia And Is Granted Extensive Patent Coverage In The US
Categorie : Cardiovascular / CardiologyEssentialis Inc, a clinical stage pharmaceutical company, announced that it met its primary endpoint of statistically significant triglyceride reduction in a 90-patient Phase 2b trial of DCCR in dyslipidemic patients. The study encompassed both patients with very high triglycerides and mixed dyslipi ...
read more Wed May 2009
New Method Significantly Improves Treatment Of Severe Heart Condition, Canadian-led Study Finds
Categorie : Cardiovascular / CardiologyThe results of an international study led by a Toronto-area doctor were unveiled today that show there's a more effective way to treat patients with a severe arrhythmia, or irregular heartbeat, than the current treatment methods. The findings were presented in Boston at Heart Rhythm 2009, the a ...
read more Wed May 2009
